J. Palmer

Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes

M. Tallman, W. Stock, D. DeAngelo, 2022, Annals of Hematology.

Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts

A. Tefferi, W. Hogan, A. Pardanani, 2022, American journal of hematology.

Adult acute leukemia.

R. Cornell, J. Palmer, 2012, Disease-a-month : DM.

A phase II study of combination daunorubicin, cytarabine (Ara‐c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression

R. Tibes, S. Hashmi, K. Begna, 2023, American journal of hematology.

Evolution of complex chromosomal rearrangements in a case of biphenotypic pre-B/myeloid acute leukemia.

D. Kangwanpong, J. Palmer, L. Secker-Walker, 1993, Cancer genetics and cytogenetics.

EXABS-163-MPN Myelofibrosis with Cytopenia.

J. Palmer, 2022, Clinical lymphoma, myeloma & leukemia.

Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms

A. Dueck, R. Tibes, H. Kosiorek, 2023, Cancer.

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

V. Najfeld, M. Salama, A. Dueck, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

Myelofibrosis

J. Palmer, Henry Knipe, 1963, The APRN and PA’s Complete Guide to Prescribing Drug Therapy.

Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia.

W. Hogan, A. Pardanani, M. Shah, 2023, Haematologica.